MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Health Catalyst Income Statement 2011-2026 | HCAT
Annual Income Statement Health Catalyst
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
298 M | 482 M | 745 M | 1.88 B | 1.72 B | 624 M | - | - | - | - | - | - | - | - |
Shares |
60.2 M | 56.4 M | 53.7 M | 47.5 M | 39.5 M | 18.7 M | - | - | - | - | - | - | - | - |
Historical Prices |
4.95 | 8.54 | 13.9 | 39.6 | 43.5 | 34.7 | - | - | - | - | - | - | - | - |
Net Income |
-69.5 M | -118 M | -137 M | -153 M | -115 M | -60.1 M | -62 M | -47 M | - | - | - | - | - | - |
Revenue |
307 M | 296 M | 276 M | 242 M | 189 M | 155 M | 113 M | 73.1 M | - | - | - | - | - | - |
Cost of Revenue |
166 M | 164 M | 143 M | 124 M | 98.1 M | 75.3 M | 59.9 M | 43.6 M | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | 79.6 M | 52.7 M | 29.4 M | - | - | - | - | - | - |
Operating Income |
-69.8 M | -127 M | -140 M | -144 M | -96.1 M | -54.9 M | -60.1 M | -45.5 M | - | - | - | - | - | - |
EBITDA |
-28.4 M | -84.7 M | -91.7 M | -106 M | -77.4 M | -45.7 M | -52.7 M | -39.6 M | - | - | - | - | - | - |
Operating Expenses |
211 M | 259 M | 273 M | 261 M | 187 M | 134 M | 113 M | 75 M | - | - | - | - | - | - |
General and Administrative Expenses |
56.8 M | 76.6 M | 61.7 M | 85.9 M | 59.2 M | 31.7 M | 22.7 M | 14.7 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Health Catalyst
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
70.4 M | 69.6 M | 68.6 M | 64 M | 60.4 M | 59.3 M | 58.6 M | 56.7 M | 55.3 M | 54.3 M | - | 53 M | 52.6 M | 49 M | 44.9 M | 43.9 M | 43.4 M | 40.3 M | 38.1 M | 37.1 M | 36.7 M | 28.2 M | 4.97 M | 4.8 M | 4.78 M | 4.69 M | 4.89 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-22.2 M | -41 M | -23.7 M | - | -14.7 M | -13.5 M | -20.6 M | -22 M | - | -45.7 M | - | -22.5 M | - | -40 M | -35.8 M | -28.4 M | - | -27.3 M | -27.2 M | -17.5 M | - | -21.4 M | -10.7 M | -13.7 M | - | -16.9 M | -19.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
76.3 M | 80.7 M | 79.4 M | - | 76.4 M | 75.9 M | 74.7 M | 73.8 M | - | 68.4 M | - | 68.1 M | - | 61.7 M | 59.6 M | 55.8 M | - | 47.2 M | 43.3 M | 45.1 M | - | 39.4 M | 36.8 M | 35.2 M | - | 32.9 M | 23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
38.5 M | 42.5 M | 43.2 M | - | 42.3 M | 40.1 M | 38.5 M | 41.8 M | - | 36.3 M | - | 34 M | - | 33.1 M | 30.1 M | 27.3 M | - | 24.4 M | 23.1 M | 24.1 M | - | 18.6 M | 17.7 M | 17.3 M | - | 17 M | 12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
40.1 M | - | - | - | 36.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-17.5 M | -37.1 M | -20.2 M | - | -13.7 M | -15.8 M | -22.8 M | -24.6 M | - | -45.7 M | - | -24.3 M | - | -42.2 M | -32.3 M | -24.3 M | - | -23.5 M | -15.6 M | -18.1 M | - | -20.7 M | -9.36 M | -11.1 M | - | -16.5 M | -18.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-4.9 M | -24.4 M | -7.85 M | - | -3.7 M | -5.15 M | -12.3 M | -14.4 M | - | -33.3 M | - | -12.7 M | - | -31.6 M | -24.2 M | -16.5 M | - | -18.5 M | -12.5 M | -15.2 M | - | -18.4 M | -7.15 M | -8.78 M | - | -14.3 M | -17.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
55.3 M | 75.3 M | 56.4 M | - | 47.7 M | 51.6 M | 59 M | 56.6 M | - | 77.7 M | - | 58.4 M | - | 70.9 M | 61.9 M | 52.8 M | - | 46.3 M | 35.8 M | 39.2 M | - | 41.5 M | 28.5 M | 29 M | - | 32.4 M | 29.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
16.1 M | 8.28 M | 14.2 M | - | 12.2 M | 14.4 M | 14.6 M | 13.6 M | - | 19.2 M | - | 8.82 M | - | 23.1 M | 22.5 M | 15 M | - | 13.3 M | 8.11 M | 9.7 M | - | 11 M | 6.15 M | 6.17 M | - | 5.6 M | 7.24 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Health Catalyst (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Health information services industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
- | - | $ 27.9 B |  USA |
 |
Change Healthcare
CHNG
|
- | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
- | - | $ 2.94 B | USA |
 |
Accolade
ACCD
|
- | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
$ 13.85 | 3.98 % | $ 237 M | USA |
 |
Progyny
PGNY
|
$ 26.8 | 0.49 % | $ 2.3 B | USA |
 |
Schrödinger
SDGR
|
$ 18.77 | 0.03 % | $ 1.36 B | USA |
 |
Evolent Health
EVH
|
$ 4.15 | 3.23 % | $ 389 M | USA |
 |
iCAD
ICAD
|
- | - | $ 102 M | USA |
 |
HealthStream
HSTM
|
$ 22.75 | -1.73 % | $ 691 M | USA |
 |
So-Young International
SY
|
$ 2.56 | -3.03 % | $ 203 M |  China |
 |
Akerna Corp.
KERN
|
- | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
$ 19.99 | 3.52 % | $ 2.34 B | USA |
 |
HealthEquity
HQY
|
$ 97.77 | 2.43 % | $ 8.37 B | USA |
 |
American Well Corporation
AMWL
|
$ 5.16 | -3.19 % | $ 77.4 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | USA |
 |
Zhongchao
ZCMD
|
$ 0.52 | -0.82 % | $ 2.71 M | China |
 |
GoodRx Holdings
GDRX
|
$ 2.85 | -1.72 % | $ 1.1 B | USA |
 |
Omnicell
OMCL
|
$ 47.45 | 0.81 % | $ 2.18 B | USA |
 |
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | USA |
 |
Phreesia
PHR
|
$ 17.52 | 1.74 % | $ 956 M | USA |
 |
Premier
PINC
|
$ 28.26 | - | $ 2.33 B | USA |
 |
R1 RCM
RCM
|
- | - | $ 3.81 B | USA |
 |
Veeva Systems
VEEV
|
$ 239.35 | 0.62 % | $ 38.4 B | USA |
 |
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | USA |
 |
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
$ 7.57 | -5.37 % | $ 1.29 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | USA |
 |
SCWorx Corp.
WORX
|
$ 0.2 | -3.59 % | $ 292 K | USA |